Literature DB >> 8363377

Facilitation of penicillin haptenation to serum proteins.

J T DiPiro1, N F Adkinson, R G Hamilton.   

Abstract

Traditionally, penicillin binding to serum proteins was believed to be a passive chemical process; however, it appears to be facilitated by serum factors. The objectives of this in vitro investigation were to examine facilitated penicillin haptenation, to study the kinetics of haptenation, and to determine the nature of haptenation-facilitating factors. The model involved addition of [3H]benzylpenicillin to serum or albumin solutions (at pH 7.3 to 7.4) and incubation at 37 degrees C for up to 72 h. The extent of penicillin binding to proteins in serum was found to be four- to fivefold higher than with solutions having comparable concentrations of purified albumin, total protein, or total immunoglobulin. Ultrafiltration of serum reduced penicillin binding to serum proteins substantially. An ultrafiltrable haptenation-facilitating factor(s) was found to be less than 0.5 kDa but was not calcium or magnesium. Finally, the extent of penicillin binding was related to albumin purity, as binding substantially increased with albumin purity. These findings suggest that there is a factor(s) in serum that facilitates covalent binding of penicillin to serum proteins. The factor(s) can be removed and then restored to increase penicillin binding to albumin. It appears that at least one component of the facilitation factor is less than 0.5 kDa, which suggests that it is not a peptide and that it is some simple serum component other than calcium or magnesium.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8363377      PMCID: PMC187995          DOI: 10.1128/AAC.37.7.1463

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  2 in total

1.  Pathogenesis and management of allergic reactions to penicillin and other beta-lactam antibiotics.

Authors:  T J Sullivan
Journal:  Pediatr Infect Dis       Date:  1982 Sep-Oct

2.  Risk factors for drug allergy.

Authors:  N F Adkinson
Journal:  J Allergy Clin Immunol       Date:  1984-10       Impact factor: 10.793

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.